Phase i/II dose-finding, safety, and tolerability study of daily rifapentine (RPT) combined with isoniazid (INH) (1HP) for tuberculosis prevention in children two to less than 13 years of age with and…
Active Awarded Last action
- Contract number
- 75N94023F00002
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,220,803
Award facts
- Opportunity
-
- NICHD Pediatric and Maternal HIV Studies DCC Pre-Solicitation · 75N94022R00003 · Posted Feb 16, 2022
- Contract value 100% obligated
- $2,220,803.00 Current and potential, with all options
- Completion date 85% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Child Health and Human Development awarded a $2.22 million cost plus fixed fee delivery order contract to Westat, Inc. to conduct a Phase I/II dose-finding, safety, and tolerability study of daily rifapentine (RPT) combined with isoniazid (INH) (1HP) for tuberculosis prevention in children two to less than 13 years of age with and without HIV. The place of performance is Potomac, Maryland and work will be conducted from June 1, 2023 through May 31, 2027.
Description
Phase i/II dose-finding, safety, and tolerability study of daily rifapentine (RPT) combined with isoniazid (INH) (1HP) for tuberculosis prevention in children two to less than 13 years of age with and without HIV
Quick answers
Who was awarded contract 75N94023F00002?
75N94023F00002 was awarded to Westat, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on June 1, 2023.
How much is contract 75N94023F00002 worth?
The government has obligated $2,220,803 on 75N94023F00002.
Is contract 75N94023F00002 an order under another contract?
Yes. 75N94023F00002 is a delivery order under 75N94023D00001, an indefinite delivery contract.
Was contract 75N94023F00002 competed?
The extent of competition for 75N94023F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award